Contents
Share Post
A patient came in last year and mentioned, almost as an aside, that his wife had lost twenty-two pounds.
I asked how.
He said she’d started a medication. GLP-1.
Her doctor had suggested it after menopause changed how her body was holding weight. She’d thought about it for a few weeks, decided it made sense, and started.
Six months later she was down twenty-two pounds and felt, in her words, like herself again.
He paused.
Then:
I’ve been thinking about it too. But I don’t know. That feels like something else.
I asked him what he meant by something else.
He looked at his hands for a moment.
“It’s the Ozempic thing. That’s not really for guys like me.”
Guys like him.
Sixty-one. Carries it in the middle. The hard belly that doesn’t give when you press it, the belt that hasn’t sat right in a few years despite doing everything reasonable.
Active. Not sedentary. Just stuck.
He is exactly who this is for. He just doesn’t know it.
Most men think GLP-1s are for influencers and actresses, not the guy quietly loosening his belt after dinner.
Here’s something that doesn’t get discussed clearly enough.
Men and women have roughly equal rates of obesity.
When GLP-1 medications are prescribed for diabetes, men and women use them at similar rates.
When prescribed specifically for weight loss, significantly more women use them than men.
Not because women need them more.
Because men don’t ask.
Most men don’t see themselves as candidates for these medications.
They see commercials, celebrity stories, social media before-and-afters, and assume it belongs to somebody else.
Meanwhile they’re carrying the exact kind of weight these medications were designed to treat—the hard abdominal weight that sits deep, drives insulin resistance, lowers testosterone, and affects vascular health long before anyone calls it a metabolic problem.
So they don’t ask about it.
They tell themselves they just need to tighten things up again.
What worked at forty often stops working at sixty.
That’s not a character failure.
The other concern men raise, when they raise it at all, is muscle.
Reasonable.
Any significant weight loss can affect lean mass, and men who’ve spent years building strength don’t want to lose it to a medication.
What I’ve seen is different.
Men who stay active on these medications usually don’t lose muscle in some dramatic way. They lose the hard abdominal weight underneath it.
And as that comes down, the downstream effects often follow—better energy, improved insulin sensitivity, lower blood pressure, better mobility, better erections.
The things he’d been filing under getting older.
His wife didn’t talk him into anything.
She just lost twenty-two pounds and felt like herself again, and he watched that happen from close enough to wonder what the equivalent looked like for him.
That’s usually how this conversation starts.
Not a BMI calculation. Not a dramatic moment.
Just watching someone close to you feel better and realizing you haven’t felt quite right in a while either.
He left with a referral for a proper evaluation.
Not a form and a shipment.
A real conversation about his metabolic health, his history, and what realistic outcomes looked like for him specifically.
A few months later he came back for something unrelated.
He looked different.
I didn’t ask.
He mentioned it on his way out.
The belt fits again.
That was the whole report.
Most of the men who would benefit from this conversation aren’t having it.
Not because the medications don’t exist.
Because the cultural frame around them still doesn’t include them.
But the hard belly that hasn’t moved despite the effort, the drifting testosterone, the energy that comes and goes, the erections that aren’t as reliable as they used to be — those are metabolic signals.
GLP-1 medications are one tool for treating the metabolic picture underneath them.
Not a shortcut. Not a trend. And not a character judgment.
For the right man, at the right time, it’s simply medicine.
